EpiBiologics | $107,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
IVIX
start up
Israel
- Tel Aviv
- 07/08/2023
- Series A
- $12,500,000
As the economy democratizes and digitizes, there is an opportunity for tax authorities to harness modern data and algorithms to drive compliance and close the tax gap. With off-the-shelf solutions for high-priority use cases, the IVIX platform provides complete, continuous visibility into the shadow economy.
Powered by artificial intelligence and machine learning, IVIX gathers and enriches publicly available business activity data to accurately identify businesses, their revenue, and the taxpayer entity.
- Industry Software Development
- Website https://www.ivix.ai/
- LinkedIn https://www.linkedin.com/company/ivix-ai/about/
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
CHAMP | $55,000,000 | (Jan 7, 2026)